CARY | CGMS | CARY / CGMS | |
Gain YTD | 3.833 | 3.999 | 96% |
Net Assets | 525M | 2.86B | 18% |
Total Expense Ratio | 0.80 | 0.39 | 205% |
Turnover | 77.00 | 39.00 | 197% |
Yield | 5.93 | 5.71 | 104% |
Fund Existence | 3 years | 3 years | - |
CARY | CGMS | |
---|---|---|
RSI ODDS (%) | 5 days ago20% | 5 days ago38% |
Stochastic ODDS (%) | 5 days ago12% | 5 days ago40% |
Momentum ODDS (%) | N/A | N/A |
MACD ODDS (%) | N/A | N/A |
TrendWeek ODDS (%) | 5 days ago70% | 5 days ago71% |
TrendMonth ODDS (%) | 5 days ago65% | 5 days ago68% |
Advances ODDS (%) | 12 days ago69% | 18 days ago69% |
Declines ODDS (%) | N/A | N/A |
BollingerBands ODDS (%) | 5 days ago6% | 5 days ago36% |
Aroon ODDS (%) | 5 days ago64% | 5 days ago62% |
A.I.dvisor tells us that CGMS and DBD have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGMS and DBD's prices will move in lockstep.
Ticker / NAME | Correlation To CGMS | 1D Price Change % | ||
---|---|---|---|---|
CGMS | 100% | -0.04% | ||
DBD - CGMS | 24% Poorly correlated | +2.16% | ||
NFE - CGMS | 16% Poorly correlated | +5.67% |